Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Search Videos by Topic or Participant
Browse by Series:

Measuring Therapeutic Response in Colon Cancer

Panelists: Axel F. Grothey, MD , Mayo Clinic ; Daniel G. Haller, MD, University of Pennsylvania; Herbert I. Hurwitz, MD, Duke University Medical Center; J
Published: Thursday, May 28, 2015
For High-Definition, Click
Given the recent advances in treatment being made for patients with colorectal cancer (CRC), it could be time to develop a new criteria to assess how a patient is responding to therapy, suggests Daniel Haller MD. Measures such as depth of response and longitudinality of response can provide practical information about whether or not to continue therapy, he adds. These approaches may explain, for instance, why the FIRE-3 study showed an improvement in overall survival without the typically prolonged progression-free survival.

It’s time to move beyond RECIST, adds John Marshall, MD. If you look at a radiology report without looking at the actual disc from a CT scan, you’ll often make the wrong clinical decision, he emphasizes. New approaches to assess responses to treatment in CRC are under development, including molecular and functional imaging techniques.

Slider Left
Slider Right
For High-Definition, Click
Given the recent advances in treatment being made for patients with colorectal cancer (CRC), it could be time to develop a new criteria to assess how a patient is responding to therapy, suggests Daniel Haller MD. Measures such as depth of response and longitudinality of response can provide practical information about whether or not to continue therapy, he adds. These approaches may explain, for instance, why the FIRE-3 study showed an improvement in overall survival without the typically prolonged progression-free survival.

It’s time to move beyond RECIST, adds John Marshall, MD. If you look at a radiology report without looking at the actual disc from a CT scan, you’ll often make the wrong clinical decision, he emphasizes. New approaches to assess responses to treatment in CRC are under development, including molecular and functional imaging techniques.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™ Decision Points in Advanced NSCLC: Assessing Treatment Options Beyond Disease ProgressionNov 30, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x